DeDora Capital’s Anixa Biosciences ANIX Stock Holding History

DeDora Capital’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.6K	Buy	+5,000	New	+$16.1K	﹤0.01%	275

Other funds holding ANIX

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

First Affirmative Financial Network Colorado Springs, Colorado $456M AUM

Gemmer Asset Management Walnut Creek, California $1.53B AUM 31.12% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Continuum Wealth Advisors Saratoga Springs, New York $307M AUM 19.33% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return

Cherry Creek Investment Advisors Englewood, Colorado $261M AUM 29.65% 1-Year Est. Return

Livelsberger Financial Advisory Ashland, Ohio $18.6M AUM

DeDora Capital's ANIX Position: Q3 2026 in Review

DeDora Capital opened a new position in Anixa Biosciences (ANIX) in Q3 2026: 5,000 shares worth $14.6K. The stake represents ﹤0.01% of the portfolio and ranks #275 among its holdings.

15 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

DeDora Capital held 5,000 shares of Anixa Biosciences worth $14.6K as of Q3 2026.
Anixa Biosciences was a new DeDora Capital position in Q3 2026.
Anixa Biosciences made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #275 holding.
15 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.